PET Chemistry The Driving Force in Molecular Imaging /
Personalized medicine employing patient-based tailor-made therapeutic drugs is taking over treatment paradigms in a variety of ?elds in oncology and the central nervous system. The success of such therapies is mainly dependent on ef?cacious therapeutic drugs and a selective imaging probe for identi?...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | , , |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Berlin, Heidelberg :
Springer Berlin Heidelberg,
2007.
|
| Σειρά: | Ernst Schering Research Foundation Workshop,
64 |
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Molecular Imaging with PET — Open Questions?
- Fluorine-18 Labeling Methods: Features and Possibilities of Basic Reactions
- Fluorine-18 Labeling of Small Molecules: The Use of 18F-Labeled Aryl Fluorides Derived from No-Carrier-Added [18F]Fluoride as Labeling Precursors
- Fluorine-18 Labeling of Peptides and Proteins
- [18F]Fluoropyridines: From Conventional Radiotracers to the Labeling of Macromolecules Such as Proteins and Oligonucleotides
- Production of Non-standard PET Radionuclides and the Application of Radiopharmaceuticals Labeled with these Nuclides
- Carbon-11 Labeling Chemistry Based upon [11C]Methyl Iodide
- 68Ga-PET Radiopharmacy: A Generator-Based Alternative to 18F-Radiopharmacy
- Microwaving in F-18 Chemistry: Quirks and Tweaks
- Micro-reactors for PET Tracer Labeling
- Synthesis Modules and Automation in F-18 Labeling
- Pharmacological Prerequisites for PET Ligands and Practical Issues in Preclinical PET Research
- Positron Emission Tomography Imaging as a Key Enabling Technology in Drug Development.
